Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Hormone Naive Prostate Cancer”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Looking for participantsNCT03833921
What this trial is testing

Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticProstate Cancer
Martha Mims 130
Testing effectiveness (Phase 2)UnknownNCT00448734
What this trial is testing

Picoplatin and Docetaxel in Subjects With Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Poniard Pharmaceuticals 95
Testing effectiveness (Phase 2)Ended earlyNCT00103428
What this trial is testing

Intravenous CG7870 in Combination With Docetaxel in Patients With Metastatic Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Cell Genesys 69
Large-scale testing (Phase 3)Active Not RecruitingNCT01957436
What this trial is testing

A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
UNICANCER 1,173
Testing effectiveness (Phase 2)Active Not RecruitingNCT03821792
What this trial is testing

Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaProstate AdenocarcinomaProstate Carcinoma Metastatic in the Bone+3 more
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT00095667
What this trial is testing

Lapatinib in Treating Patients With Recurrent or Metastatic Prostate Cancer

Who this might be right for
Recurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT04343885
What this trial is testing

In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy

Who this might be right for
Metastatic Hormone Naive Prostate Cancer
Peter MacCallum Cancer Centre, Australia 130
Testing effectiveness (Phase 2)Study completedNCT03707184
What this trial is testing

Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone

Who this might be right for
Metastatic Prostate CarcinomaProstate Carcinoma Metastatic in the BoneStage IV Prostate Cancer
University of Utah 17
Large-scale testing (Phase 3)Study completedNCT01715285
What this trial is testing

Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)

Who this might be right for
Prostate Neoplasms
Janssen Research & Development, LLC 1,209